Thermogenesis Holdings Valuation
| THMODelisted Stock | USD 0.32 0.01 3.03% |
Thermogenesis Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Thermogenesis Holdings from inspecting the company fundamentals such as Shares Outstanding of 7.95 M, operating margin of (0.20) %, and Return On Equity of -8.02 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Thermogenesis Holdings' price fluctuation is very steady at this time. Calculation of the real value of Thermogenesis Holdings is based on 3 months time horizon. Increasing Thermogenesis Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Thermogenesis Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Thermogenesis Stock. However, Thermogenesis Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.32 | Real 0.3 | Hype 0.32 |
The intrinsic value of Thermogenesis Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Thermogenesis Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Thermogenesis Holdings helps investors to forecast how Thermogenesis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Thermogenesis Holdings more accurately as focusing exclusively on Thermogenesis Holdings' fundamentals will not take into account other important factors: Thermogenesis Holdings Total Value Analysis
Thermogenesis Holdings is at this time expected to have valuation of 6.8 M with market capitalization of 2.47 M, debt of 10.56 M, and cash on hands of 3.9 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Thermogenesis Holdings fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.8 M | 2.47 M | 10.56 M | 3.9 M |
Thermogenesis Holdings Investor Information
About 56.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Thermogenesis Holdings recorded a loss per share of 3.98. The entity last dividend was issued on the 5th of June 2019. The firm had 1:45 split on the 22nd of December 2022. Based on the key indicators related to Thermogenesis Holdings' liquidity, profitability, solvency, and operating efficiency, Thermogenesis Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Thermogenesis Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Thermogenesis Holdings has an asset utilization ratio of 84.09 percent. This suggests that the Company is making $0.84 for each dollar of assets. An increasing asset utilization means that Thermogenesis Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Thermogenesis Holdings Ownership Allocation
Thermogenesis Holdings maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Thermogenesis Holdings Profitability Analysis
The company reported the previous year's revenue of 9.45 M. Net Loss for the year was (18.92 M) with profit before overhead, payroll, taxes, and interest of 3.49 M.About Thermogenesis Holdings Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Thermogenesis Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Thermogenesis Holdings based exclusively on its fundamental and basic technical indicators. By analyzing Thermogenesis Holdings's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Thermogenesis Holdings's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Thermogenesis Holdings. We calculate exposure to Thermogenesis Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Thermogenesis Holdings's related companies.ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor and other cell-based therapies. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. Thermogenesis Holdings operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs people.
Thermogenesis Holdings Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.4 M | |
| Forward Price Earnings | 2.2946 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Thermogenesis Stock
If you are still planning to invest in Thermogenesis Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thermogenesis Holdings' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world |